Selskabsvedtægter for Genmab A/S

April 20, 2011 01:48 ET | Source: Genmab A/S Genmab A/S

Se venligst vedhæftede selskabsvedtægter for Genmab A/S.

Kontakt:
Helle Husted, Vice President, Investor Relations
T: +45 33 44 77 30
M: +45 25 27 47 13
E: h.husted@genmab.com
www.genmab.com

Attachments

Articles of Association-DK- 6 April 2011 II.pdf...

Recommended Reading

January 29, 2026 12:49 ET | Source: Genmab A/S

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; January 29, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 32,806 restricted stock units and 34,307 warrants...
Read More
January 21, 2026 06:23 ET | Source: Genmab A/S

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025

Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)...
Read More